These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10398734)

  • 1. Early morphology of accelerated vein graft atheroma in experimental vein grafts.
    Davies MG; Huynh TT; Fulton GJ; Barber L; Svendsen E; Hagen PO
    Ann Vasc Surg; 1999 Jul; 13(4):378-85. PubMed ID: 10398734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma.
    Davies MG; Fulton GJ; Huynh TT; Barber L; Svendsen E; Hagen PO
    Ann Vasc Surg; 1999 Sep; 13(5):484-93. PubMed ID: 10466992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts.
    Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
    J Surg Res; 1994 Jul; 57(1):106-21. PubMed ID: 8041125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
    J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
    Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits--a potential role in vein graft atherosclerosis.
    Hanyu M; Kume N; Ikeda T; Minami M; Kita T; Komeda M
    Atherosclerosis; 2001 Oct; 158(2):313-9. PubMed ID: 11583709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular clips have no significant effect on the cellular proliferation, intimal changes, or peak systolic velocity at anastomoses in rabbit vein grafts.
    Caiati JM; Madigan JD; Bhagat G; Benvenisty AI; Nowygrod R; Todd GJ
    J Surg Res; 2000 Jul; 92(1):29-35. PubMed ID: 10864478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramipril and experimental vein graft intimal hyperplasia.
    Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
    Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells.
    Ohta S; Komori K; Yonemitsu Y; Onohara T; Matsumoto T; Sugimachi K
    Surgery; 2002 Jun; 131(6):644-53. PubMed ID: 12075177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia alters the gene expression of novel components of the extracellular matrix in experimental vein grafts.
    Dattilo JB; Dattilo MP; Yager DR; Makhoul RG
    Ann Vasc Surg; 1998 Mar; 12(2):168-73. PubMed ID: 9514237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.